ELEVANCE HEALTH INC (1ANTM.MI) Fundamental Analysis & Valuation

BIT:1ANTM • US0367521038

Current stock price

315.5 EUR
+11.3 (+3.71%)
Last:

This 1ANTM.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. 1ANTM.MI Profitability Analysis

1.1 Basic Checks

  • 1ANTM had positive earnings in the past year.
  • In the past year 1ANTM had a positive cash flow from operations.
  • Each year in the past 5 years 1ANTM has been profitable.
  • In the past 5 years 1ANTM always reported a positive cash flow from operatings.
1ANTM.MI Yearly Net Income VS EBIT VS OCF VS FCF1ANTM.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

1.2 Ratios

  • 1ANTM has a Return On Assets of 4.51%. This is in the better half of the industry: 1ANTM outperforms 78.13% of its industry peers.
  • Looking at the Return On Equity, with a value of 12.59%, 1ANTM is in the better half of the industry, outperforming 68.75% of the companies in the same industry.
  • 1ANTM has a Return On Invested Capital of 5.60%. This is comparable to the rest of the industry: 1ANTM outperforms 53.13% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for 1ANTM is in line with the industry average of 6.44%.
Industry RankSector Rank
ROA 4.51%
ROE 12.59%
ROIC 5.6%
ROA(3y)5.45%
ROA(5y)5.58%
ROE(3y)15.32%
ROE(5y)15.33%
ROIC(3y)6.9%
ROIC(5y)7.19%
1ANTM.MI Yearly ROA, ROE, ROIC1ANTM.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • 1ANTM has a better Profit Margin (2.84%) than 65.63% of its industry peers.
  • In the last couple of years the Profit Margin of 1ANTM has declined.
  • Looking at the Operating Margin, with a value of 4.35%, 1ANTM is in line with its industry, outperforming 56.25% of the companies in the same industry.
  • In the last couple of years the Operating Margin of 1ANTM has declined.
Industry RankSector Rank
OM 4.35%
PM (TTM) 2.84%
GM N/A
OM growth 3Y-7.78%
OM growth 5Y-4.45%
PM growth 3Y-8.42%
PM growth 5Y-6.01%
GM growth 3YN/A
GM growth 5YN/A
1ANTM.MI Yearly Profit, Operating, Gross Margins1ANTM.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6

2

2. 1ANTM.MI Health Analysis

2.1 Basic Checks

  • 1ANTM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, 1ANTM has less shares outstanding
  • The number of shares outstanding for 1ANTM has been reduced compared to 5 years ago.
  • 1ANTM has a worse debt/assets ratio than last year.
1ANTM.MI Yearly Shares Outstanding1ANTM.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
1ANTM.MI Yearly Total Debt VS Total Assets1ANTM.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

  • The Debt to FCF ratio of 1ANTM is 8.63, which is on the high side as it means it would take 1ANTM, 8.63 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of 1ANTM (8.63) is comparable to the rest of the industry.
  • 1ANTM has a Debt/Equity ratio of 0.71. This is a neutral value indicating 1ANTM is somewhat dependend on debt financing.
  • 1ANTM's Debt to Equity ratio of 0.71 is amongst the best of the industry. 1ANTM outperforms 81.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF 8.63
Altman-Z N/A
ROIC/WACC0.66
WACC8.46%
1ANTM.MI Yearly LT Debt VS Equity VS FCF1ANTM.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
1ANTM.MI Yearly Current Assets VS Current Liabilites1ANTM.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

4

3. 1ANTM.MI Growth Analysis

3.1 Past

  • 1ANTM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -11.71%.
  • Measured over the past years, 1ANTM shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.17% on average per year.
  • The Revenue has grown by 11.96% in the past year. This is quite good.
  • The Revenue has been growing by 11.14% on average over the past years. This is quite good.
EPS 1Y (TTM)-11.71%
EPS 3Y8.28%
EPS 5Y11.17%
EPS Q2Q%-27.96%
Revenue 1Y (TTM)11.96%
Revenue growth 3Y8.44%
Revenue growth 5Y11.14%
Sales Q2Q%12%

3.2 Future

  • 1ANTM is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.64% yearly.
  • The Revenue is expected to grow by 4.62% on average over the next years.
EPS Next Y-8.14%
EPS Next 2Y-8.99%
EPS Next 3Y-1.44%
EPS Next 5Y7.64%
Revenue Next Year13.09%
Revenue Next 2Y8.09%
Revenue Next 3Y6.88%
Revenue Next 5Y4.62%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
1ANTM.MI Yearly Revenue VS Estimates1ANTM.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 50B 100B 150B 200B
1ANTM.MI Yearly EPS VS Estimates1ANTM.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20 40 60

4

4. 1ANTM.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 11.95, which indicates a very decent valuation of 1ANTM.
  • Based on the Price/Earnings ratio, 1ANTM is valued a bit cheaper than 75.00% of the companies in the same industry.
  • 1ANTM is valuated cheaply when we compare the Price/Earnings ratio to 25.73, which is the current average of the S&P500 Index.
  • 1ANTM is valuated correctly with a Price/Forward Earnings ratio of 13.42.
  • 65.63% of the companies in the same industry are more expensive than 1ANTM, based on the Price/Forward Earnings ratio.
  • 1ANTM's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.72.
Industry RankSector Rank
PE 11.95
Fwd PE 13.42
1ANTM.MI Price Earnings VS Forward Price Earnings1ANTM.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 1ANTM's Enterprise Value to EBITDA ratio is in line with the industry average.
  • Based on the Price/Free Cash Flow ratio, 1ANTM is valued a bit more expensive than 65.63% of the companies in the same industry.
Industry RankSector Rank
P/FCF 21.89
EV/EBITDA 10.45
1ANTM.MI Per share data1ANTM.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 200 400 600

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)1.07
EPS Next 2Y-8.99%
EPS Next 3Y-1.44%

5

5. 1ANTM.MI Dividend Analysis

5.1 Amount

  • 1ANTM has a Yearly Dividend Yield of 1.79%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 1.69, 1ANTM pays a bit more dividend than its industry peers.
  • 1ANTM's Dividend Yield is comparable with the S&P500 average which is at 1.91.
Industry RankSector Rank
Dividend Yield 1.79%

5.2 History

  • On average, the dividend of 1ANTM grows each year by 15.34%, which is quite nice.
Dividend Growth(5Y)15.34%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

  • 27.56% of the earnings are spent on dividend by 1ANTM. This is a low number and sustainable payout ratio.
  • 1ANTM's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP27.56%
EPS Next 2Y-8.99%
EPS Next 3Y-1.44%
1ANTM.MI Yearly Income VS Free CF VS Dividend1ANTM.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B
1ANTM.MI Dividend Payout.1ANTM.MI Dividend Payout, showing the Payout Ratio.1ANTM.MI Dividend Payout.PayoutRetained Earnings

1ANTM.MI Fundamentals: All Metrics, Ratios and Statistics

ELEVANCE HEALTH INC

BIT:1ANTM (1/7/2026, 7:00:00 PM)

315.5

+11.3 (+3.71%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-21
Earnings (Next)01-28
Inst Owners91.68%
Inst Owner ChangeN/A
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap70.12B
Revenue(TTM)194.82B
Net Income(TTM)5.53B
Analysts73.57
Price Target335.28 (6.27%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.79%
Yearly Dividend5.64
Dividend Growth(5Y)15.34%
DP27.56%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)9.38%
Min EPS beat(2)-2.26%
Max EPS beat(2)21.02%
EPS beat(4)3
Avg EPS beat(4)5.76%
Min EPS beat(4)-2.26%
Max EPS beat(4)21.02%
EPS beat(8)5
Avg EPS beat(8)0.95%
EPS beat(12)8
Avg EPS beat(12)1.31%
EPS beat(16)11
Avg EPS beat(16)1.68%
Revenue beat(2)2
Avg Revenue beat(2)0.95%
Min Revenue beat(2)0.45%
Max Revenue beat(2)1.45%
Revenue beat(4)3
Avg Revenue beat(4)1.37%
Min Revenue beat(4)-0.71%
Max Revenue beat(4)4.3%
Revenue beat(8)5
Avg Revenue beat(8)0.79%
Revenue beat(12)7
Avg Revenue beat(12)1%
Revenue beat(16)10
Avg Revenue beat(16)0.86%
PT rev (1m)5.44%
PT rev (3m)5.44%
EPS NQ rev (1m)-24.94%
EPS NQ rev (3m)-24.94%
EPS NY rev (1m)0.31%
EPS NY rev (3m)0.31%
Revenue NQ rev (1m)0.32%
Revenue NQ rev (3m)0.32%
Revenue NY rev (1m)0.68%
Revenue NY rev (3m)0.68%
Valuation
Industry RankSector Rank
PE 11.95
Fwd PE 13.42
P/S 0.42
P/FCF 21.89
P/OCF 16.74
P/B 1.85
P/tB 19.51
EV/EBITDA 10.45
EPS(TTM)26.41
EY8.37%
EPS(NY)23.51
Fwd EY7.45%
FCF(TTM)14.41
FCFY4.57%
OCF(TTM)18.85
OCFY5.97%
SpS754.6
BVpS170.24
TBVpS16.17
PEG (NY)N/A
PEG (5Y)1.07
Graham Number318.06
Profitability
Industry RankSector Rank
ROA 4.51%
ROE 12.59%
ROCE 7.32%
ROIC 5.6%
ROICexc 6.06%
ROICexgc 10.93%
OM 4.35%
PM (TTM) 2.84%
GM N/A
FCFM 1.91%
ROA(3y)5.45%
ROA(5y)5.58%
ROE(3y)15.32%
ROE(5y)15.33%
ROIC(3y)6.9%
ROIC(5y)7.19%
ROICexc(3y)7.45%
ROICexc(5y)7.72%
ROICexgc(3y)13.9%
ROICexgc(5y)14.63%
ROCE(3y)9.03%
ROCE(5y)9.4%
ROICexgc growth 3Y-5.49%
ROICexgc growth 5Y-3.16%
ROICexc growth 3Y-5.02%
ROICexc growth 5Y-2.23%
OM growth 3Y-7.78%
OM growth 5Y-4.45%
PM growth 3Y-8.42%
PM growth 5Y-6.01%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover1.59
Health
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF 8.63
Debt/EBITDA 3.13
Cap/Depr 74.45%
Cap/Sales 0.59%
Interest Coverage 250
Cash Conversion 48.59%
Profit Quality 67.25%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACC8.46%
ROIC/WACC0.66
Cap/Depr(3y)77.74%
Cap/Depr(5y)81.03%
Cap/Sales(3y)0.73%
Cap/Sales(5y)0.76%
Profit Quality(3y)103.66%
Profit Quality(5y)128.32%
High Growth Momentum
Growth
EPS 1Y (TTM)-11.71%
EPS 3Y8.28%
EPS 5Y11.17%
EPS Q2Q%-27.96%
EPS Next Y-8.14%
EPS Next 2Y-8.99%
EPS Next 3Y-1.44%
EPS Next 5Y7.64%
Revenue 1Y (TTM)11.96%
Revenue growth 3Y8.44%
Revenue growth 5Y11.14%
Sales Q2Q%12%
Revenue Next Year13.09%
Revenue Next 2Y8.09%
Revenue Next 3Y6.88%
Revenue Next 5Y4.62%
EBIT growth 1Y-10.69%
EBIT growth 3Y0%
EBIT growth 5Y6.19%
EBIT Next Year-2.04%
EBIT Next 3Y0.56%
EBIT Next 5Y8.31%
FCF growth 1Y-54.88%
FCF growth 3Y-14.89%
FCF growth 5Y-2.08%
OCF growth 1Y-48.85%
OCF growth 3Y-11.78%
OCF growth 5Y-1.08%

ELEVANCE HEALTH INC / 1ANTM.MI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ELEVANCE HEALTH INC (1ANTM.MI) stock?

ChartMill assigns a fundamental rating of 4 / 10 to 1ANTM.MI.


What is the valuation status of ELEVANCE HEALTH INC (1ANTM.MI) stock?

ChartMill assigns a valuation rating of 5 / 10 to ELEVANCE HEALTH INC (1ANTM.MI). This can be considered as Fairly Valued.


How profitable is ELEVANCE HEALTH INC (1ANTM.MI) stock?

ELEVANCE HEALTH INC (1ANTM.MI) has a profitability rating of 4 / 10.


What is the financial health of ELEVANCE HEALTH INC (1ANTM.MI) stock?

The financial health rating of ELEVANCE HEALTH INC (1ANTM.MI) is 3 / 10.


What is the expected EPS growth for ELEVANCE HEALTH INC (1ANTM.MI) stock?

The Earnings per Share (EPS) of ELEVANCE HEALTH INC (1ANTM.MI) is expected to decline by -8.14% in the next year.